The significant loss of cytokeratin 18 (KRT18), a well described luminal breast cancer marker, is worth mentioning, as the sole knockdown of KRT18 has been recently shown to induce EMT and stemness features in non-metastatic MCF-7 breast cancer cells [49]. This evidence concerns the gene KRT18 and breast carcinoma.